As States Legalize Marijuana, Investors See an Opportunity
- 6 years ago
As States Legalize Marijuana, Investors See an Opportunity
The safest investment is in legal businesses like pharmaceutical companies using cannabis in their treatments as well as companies
that make devices to consume cannabis, create sales and tracking software, develop or manage the real estate related to cannabis, or even provide human resources to the industry.
Investors put $500 million into private cannabis companies last year, said Troy Dayton, the chief executive
and a co-founder of Arcview, which also has an investment arm.
Arcview said 2.3 million people in the United States used marijuana for medical purposes last year and
that an additional 1.8 million did so recreationally in states where it was legal.
Since 2011, his group, which consists of 600 investors, has made $155 million worth of investments in the cannabis industry, from growers
and dispensaries to companies that make ancillary products, like vaping devices.
We’re trying to create a path that allows the doctors and hospitals to use this as another way of treating a patient.”
Steven W. Wasserman, a lawyer and investment adviser at Seaport Investment Management in New York, said
he had invested 5 percent of his own money into six cannabinoid-based pharmaceutical companies.
The safest investment is in legal businesses like pharmaceutical companies using cannabis in their treatments as well as companies
that make devices to consume cannabis, create sales and tracking software, develop or manage the real estate related to cannabis, or even provide human resources to the industry.
Investors put $500 million into private cannabis companies last year, said Troy Dayton, the chief executive
and a co-founder of Arcview, which also has an investment arm.
Arcview said 2.3 million people in the United States used marijuana for medical purposes last year and
that an additional 1.8 million did so recreationally in states where it was legal.
Since 2011, his group, which consists of 600 investors, has made $155 million worth of investments in the cannabis industry, from growers
and dispensaries to companies that make ancillary products, like vaping devices.
We’re trying to create a path that allows the doctors and hospitals to use this as another way of treating a patient.”
Steven W. Wasserman, a lawyer and investment adviser at Seaport Investment Management in New York, said
he had invested 5 percent of his own money into six cannabinoid-based pharmaceutical companies.